Dan Benjamin Teleman insider trades

Open-market stock purchases and sales by Dan Benjamin Teleman, Chief Executive Officer at Nasus Pharma Ltd, from SEC Form 4 filings since Mar 31, 2026.

Recent trades

DateStockTradeValue
Jun 17, 2026NSRX Nasus Pharma LtdBought$20.3K
Apr 22, 2026NSRX Nasus Pharma LtdBought$10.9K
Mar 31, 2026NSRX Nasus Pharma LtdBought$30.6K

Companies traded

  • NSRX Nasus Pharma Ltd: 3 buys, last Jun 17, 2026

Get free alerts when Dan Benjamin Teleman files a new trade →